Published on in Vol 8, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33859, first published .
Making National Cancer Institute–Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study

Making National Cancer Institute–Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study

Making National Cancer Institute–Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study

Maitri Kalra 1, MBBS;  Elizabeth Henry 2, MD;  Kelly McCann 3, MD, PhD;  Meghan S Karuturi 4, MD;  Jean G Bustamante Alvarez 5, MS, MD;  Amanda Parkes 6, MD;  Robert Wesolowski 7, MD;  Mei Wei 8, MD;  Sarah S Mougalian 9, MD;  Gregory Durm 10, MD;  Angel Qin 11, MD;  Caitlin Schonewolf 11, MD;  Meghna Trivedi 12, MD;  Avan J Armaghani 13, MD;  Frederick H Wilson 9, MD;  Wade T Iams 14, MD;  Anita A Turk 10, MD;  Praveen Vikas 15, MD;  Michael Cecchini 9, MD;  Sam Lubner 6, MD;  Priyadarshini Pathak 10, MD;  Kristen Spencer 16, MD;  Vadim S Koshkin 3, MD;  Matthew K Labriola 17, MD;  Catherine H Marshall 18, MD;  Katy E Beckermann 14, MD;   theMednet.org NCI-CCC Tumor Board Program Collaborative Group 19;  Marina N Sharifi 6, MD, PhD;  Anthony C Bejjani 20, MD;  Varsha Hotchandani 19, MS;  Samir Housri 19, MBA;  Nadine Housri 9, MD

1 Division of Hematology/Oncology, Department of Medicine, Indiana University Health Ball Memorial Hospital, Fishers, IN, US

2 Division of Hematology/Oncology, Department of Medicine, Loyola University Stritch School of Medicine, Maywood, IL, US

3 Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Beverly Hills, CA, US

4 Division of Hematology/Oncology, Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

5 Division of Hematology/Oncology, Department of Medicine, West Virginia University, Morgantown, WV, US

6 Division of Hematology/Oncology, Department of Medicine, University of Wisconsin, Madison, WI, US

7 Division of Hematology/Oncology, Department of Medicine, Ohio State University, Columbus, OH, US

8 Division of Hematology/Oncology, Department of Medicine, University of Utah, Utah City, UT, US

9 Department of Radiation/Oncology, Yale University School of Medicine , New Haven, CT, US

10 Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, US

11 Department of Radiation Oncology, University of Michigan , Ann Arbor, MI, US

12 Division of Hematology/Oncology, Department of Medicine, Herbert-Irving Comprehensive Cancer Center, Columbia University, New York, NY, US

13 Division of Hematology/Oncology, Department of Medicine, Moffitt Cancer Center University of South Florida, Tampa, FL, US

14 Division of Oncology, Department of Medicine, Vanderbilt University, Nashville, TN, US

15 Division of Hematology/Oncology, Department of Medicine, University of Iowa, Iowa City, IA, US

16 Division of Hematology/Oncology, Department of Medicine, Rutgers University Cancer Institute of New Jersey, New Brunswick, NJ, US

17 Division of Hematology/Oncology, Department of Medicine, Duke University, Durham, NC, US

18 Division of Oncology, Department of Medicine, Johns Hopkins University, Baltimore, MD, US

19 Mednet Inc , New York, NY, US

20 Division of Hematology/Oncology, Department of Medicine, Veterans Health Administration Greater Los Angeles Health System, Los Angeles, CA, US

Corresponding Author:

  • Maitri Kalra, MBBS
  • Division of Hematology/Oncology
  • Department of Medicine
  • Indiana University Health Ball Memorial Hospital
  • 12261 Shady Knoll Drive
  • Fishers, IN
  • US
  • Phone: 1 317-440-1066
  • Email: maitribhandari@gmail.com